Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Austco Healthcare Limited ( (AU:AHC) ) has provided an announcement.
Austco Healthcare Limited has announced the cessation of 393,946 performance rights, which lapsed on 5 January 2026 because the conditions attached to these rights were not met or became incapable of being satisfied. The lapse of these conditional rights modestly reduces Austco’s potential future share issuance, slightly simplifying its capital structure and signaling that certain performance or service milestones tied to executive or employee incentives were not achieved within the prescribed timeframe.
The most recent analyst rating on (AU:AHC) stock is a Buy with a A$0.55 price target. To see the full list of analyst forecasts on Austco Healthcare Limited stock, see the AU:AHC Stock Forecast page.
More about Austco Healthcare Limited
Austco Healthcare Limited is an Australian-listed company in the healthcare technology sector, trading on the ASX under the code AHC. The company is known for providing communication and clinical workflow solutions to hospitals and aged care facilities, with a focus on nurse call systems and related healthcare communication technologies.
Average Trading Volume: 190,288
Technical Sentiment Signal: Buy
Current Market Cap: A$151.8M
For an in-depth examination of AHC stock, go to TipRanks’ Overview page.